Good afternoon :)
$
₹
Kenvue Inc.

Kenvue Inc.

KVUE

NYSE
Asset Logo

Kenvue Inc.

KVUE

NYSE
$17.910.02% (+0.00)
$
₹
$17.910.02% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Consumer Defensive

Household & Personal Products

Large Cap

With a market cap of $34.2B the stock is ranked 440

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

20.91
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

3.23
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$0.85
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.41
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

10.76%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

4.67%

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 19 analysts' reports

Buy
5 analysts
Hold
14 analysts
Sell
0 analyst

Analysts expect a +8.82% price upside over the next year

Current Price$17.91
Target Price$19.5

Company Profile

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Peers

Peers

Unilever PLC ADR
UL
Unilever PLC ADR
P/E Ratio
20.95
20.95
1Y Return
1.06%
1.06%
Buy Reco %
80.00
80.00
Estee Lauder Companies Inc
EL
Estee Lauder Companies Inc
P/E Ratio
194.24
194.24
1Y Return
10.12%
10.12%
Buy Reco %
44.00
44.00
ELF Beauty Inc
ELF
ELF Beauty Inc
P/E Ratio
98.88
98.88
1Y Return
33.87%
33.87%
Buy Reco %
70.58
70.58
Inter Parfums Inc
IPAR
Inter Parfums Inc
P/E Ratio
21.41
21.41
1Y Return
3.58%
3.58%
Buy Reco %
100.00
100.00
Coty Inc
COTY
Coty Inc
P/E Ratio
—
—
1Y Return
36.29%
36.29%
Buy Reco %
40.00
40.00

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
Consumer DefensiveHousehold & Personal Products

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Kenvue Inc. 20.913.231.41
Unilever PLC ADR20.957.0810.62
Estee Lauder Companies Inc194.249.232.12

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

3.7
0.3
3.7
0.3
3.9
0.4
3.9
0.4
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue3.8943.893.663.743.833.763.783.903.95
Net Income0.290.050.380.290.320.420.390.330.470.45
Net Profit Margin7.60%1.45%9.82%8.00%8.60%10.94%10.57%8.73%12.12%11.52%
See CostsAll values in $ Billion

Frequently asked questions

Frequently asked questions

  1. Kenvue Inc. (KVUE) share price today is $17.91 as of September 16, 2026 at 1:30 AM IST. The stock touched a day high of $17.92 and a day low of $17.70.

  2. Kenvue Inc. stock trades on NYSE under the ticker symbol KVUE.

  3. Kenvue Inc.'s market capitalization is $34.15B as of September 16, 2026 at 1:30 AM IST.

  4. Kenvue Inc.'s price-to-earnings (P/E) ratio is 20.91 as of September 15, 2026.

  5. Kenvue Inc.'s price-to-book (P/B) ratio is 3.23 as of September 15, 2026.

  6. Yes, Kenvue Inc. pays a dividend, with a current dividend yield of 4.67%.

  7. Yes, You can buy Kenvue Inc. shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Kenvue Inc. shares in three steps: 1. Search Kenvue Inc. on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Kenvue Inc. trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Kenvue Inc. (KVUE) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.5581 shares at the current price of $17.91.

Loading...